Ian R. Friedland

Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)

Joseph S. Solomkin, Ellie Hershberger, Benjamin Miller et al. · Clinical Infectious Diseases · 2015 · 410 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i> from Hospitalized Patients in the United States, 1998 to 2001

James A. Karlowsky, Deborah C. Draghi, Mark E. Jones et al. · Antimicrobial Agents and Chemotherapy · 2003 · 353 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study*

Jean Chastre, Richard G. Wunderink, Philippe Prokocimer et al. · Critical Care Medicine · 2008 · 241 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis

Keith P. Klugman, Ian R. Friedland, John S. Bradley · Antimicrobial Agents and Chemotherapy · 1995 · 239 citations

Pharmacy, Infectious Diseases, Microbiology +16

Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

Ian R. Friedland, Maria Paris, S. Ehrett et al. · Antimicrobial Agents and Chemotherapy · 1993 · 237 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +15